Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SHAREHOLDER ALERT: Weiss Law Investigates Oak Street Health, Inc.

CVS

NEW YORK, Feb. 8, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Oak Street Health, Inc. ("Oak Street" or the "Company") (NYSE: OSH), in connection with the proposed acquisition of the Company by CVS Health Corporation (NYSE: CVS). Under the terms of the merger agreement, the Company's shareholders will receive $39.00 in cash for each share of Oak Street common stock owned. The transaction is valued at approximately $10.6 billion.

(PRNewsfoto/WeissLaw LLP)

If you own Oak Street shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:

https://www.weisslaw.co/news-and-cases/osh
Or please contact:
Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Weiss Law is investigating whether (i) Oak Street's board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the $39.00 per share merger consideration adequately compensates Oak Street's shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed. Notably, at least one analyst set a price target for the Company of $47 per share, $8.00 above the per-share merger consideration.

Weiss Law has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-weiss-law-investigates-oak-street-health-inc-301742421.html

SOURCE Weiss Law



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today